Cooley and Wilson Sonsini Goodrich & Rosati have advised Candid Therapeutics. Covington & Burling has represented UCB. UCB, a global biopharmaceutical company, has announced a definitive...
UCB to Acquire Candid Therapeutics in $2.2 Billion Deal
UCB Acquires Neurona Therapeutics in $1.15 Billion Deal
Covington has advised UCB. Wilson Sonsini Goodrich & Rosati has advised Neurona Therapeutics. UCB, a global biopharmaceutical company, has entered into a definitive agreement to acquire...


























